Dengue Vax/Zika Challenge (CIR 369)
Outpatient Study enrolling healthy adults 18-40 years old
The purpose of this study is to test the effects of the ZIKA virus against a Dengue vaccine. We hope to see if the Dengue vaccine is effective to protect individuals against the Zika virus.
The study is:
- 1 year long
- enrolling healthy adults 18-40 years old
- at least 2 screening visits
- 1 vaccination visit
- 12 follow up visits after vaccination
- 1 zika challenge visit
- 19 follow up visits after challenge
Screening Dates
Thursday, June 6, 2024
Tuesday, June 11, 2024
Thursday, June 13, 2024
Tuesday, June 18, 2024
Friday, June 21, 2024
Tuesday, June 25, 2024
Tuesday, July 2, 2024
Tuesday, July 9, 2024
Wednesday, July 10, 2024
Tuesday, July 16, 2024
Wednesday, July 17, 2024
Screening Location(s)
CIR Johns Hopkins East Baltimore Campus
Rangos Building
855 N. Wolfe Street Suite 601
Baltimore, MD 21205
Study Period
One year
Compensation
Up to $6100